Nicotinic Modulation of the Default Network

Clinical trial NCT01223404 · COMPLETED

Trial details

NCT number: NCT01223404
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Magnetic Resonance Imaging Cognition Nicotine Mecamylamine

Start date: 2010-10-01
Primary completion: 2013-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.